APA (7th ed.) Citation

RCM, T., C, F., C, W., DMC, V. J., A, T., W, v. R., . . . BC, J. (2023). High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome. Neurology(R) neuroimmunology & neuroinflammation, 10(4), . https://doi.org/10.1212/NXI.0000000000200107

Chicago Style (17th ed.) Citation

RCM, Thomma, Fokke C, Walgaard C, Vermeulen-de Jongh DMC, Tio-Gillen A, van Rijs W, van Doorn PA, Huizinga R, and Jacobs BC. "High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome." Neurology(R) Neuroimmunology & Neuroinflammation 10, no. 4 (2023). https://doi.org/10.1212/NXI.0000000000200107.

MLA (9th ed.) Citation

RCM, Thomma, et al. "High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome." Neurology(R) Neuroimmunology & Neuroinflammation, vol. 10, no. 4, 2023, https://doi.org/10.1212/NXI.0000000000200107.